End-to-end partner
of NNP drug development
SHIFTBIO enables the loading of a wide range of therapeutics onto NNPs.
We provide a new type of drug development service.
 |  |
We developed NNP Sorting Motif by identifying specific amino acid sequence that effectively traffic drug targets to NNPs. | |
NSM is a powerful platform
technology that surpasses existing
NNP engineering technology.
The key to SHIFTBIO's NNP therapy
development is the technology
for loading drug targets.
Through our optimized NNP therapy
development strategy,
we can expedite the new drug
development process.
Identification of promising drug candidates
Loading of drug candidate based on NSM platform
Efficacy test
Establishing strategies for CMC / RA / IP
SHIFTBIO can verify promising early
drug candidates from partners and
apply NSM platform technology.
Based on an optimized NNP therapeutics development strategy,
we provide the essential elements
for each milestone and jointly advance
the development of novel therapeutics.
SHIFTBIO's AI-driven NSM platform technology is a technique for predicting the efficiency of loading therapeutics within NNPs and the therapeutic efficacy of the payloads. |
 | |
Optimizing the | Predicting |
Our AI-driven NSM platform
technology significantly reduces
the time and cost required for
identifying NNP drug candidates.
End-to-end partner of NNP drug development
NNP Sorting Motif (NSM)
SHIFTBIO enables the loading of a wide range of therapeutics onto NNPs.
We provide a new type of drug development service.
| |
We developed NNP Sorting Motif by identifying specific amino acid sequence that effectively traffic drug targets to NNPs. | |
NSM is a powerful platform technology
that surpasses existing NNP engineering technology.
SHIFTBIO Drug Development Process
The key to SHIFTBIO's NNP therapy development is the technology for loading drug targets.
Through our optimized NNP therapy development strategy,
we can expedite the new drug development process.
Identification of promising drug candidates
Loading of drug candidate based on NSM platform
Efficacy test
Establishing strategies for CMC / RA / IP
SHIFTBIO can verify promising early drug candidates from partners and apply NSM platform technology. Based on an optimized NNP therapeutics development strategy, we provide the essential elements for each milestone and jointly advance the development of novel therapeutics.
AI-Driven NSM Platform
SHIFTBIO's AI-driven NSM platform technology is a technique for predicting
the efficiency of loading therapeutics within NNPs and the therapeutic efficacy of the payloads.
| |
Optimizing the structure of cargo and NSM for enhanced loading efficiency | Predicting cargo-receptor binding affinity for efficient drug screening |
Our AI-driven NSM platform technology significantly reduces
the time and cost required for identifying NNP drug candidates.
